Showing 761-770 of 987 results for "".
- BIOCORNEUM® Expands Product Line With New Bruise, Scar Recovery Solutionshttps://modernaesthetics.com/news/biocorneum-expands-product-line-with-new-bruise-scar-recovery-solutions/2484030/BIOCORNEUM® unveiled new additions to its recovery line during Plastic Surgery The Meeting, held October 9–12 in New Orleans. The brand introduced its new Bruise Care System, featuring a topical cream and an oral supplement designed for patients und
- Dr. Woolery-Lloyd Appointed Program Development Advisor for Skin of Color Updatehttps://modernaesthetics.com/news/dr-woolery-lloyd-appointed-program-development-advisor-for-skin-of-color-update/2484015/Heather Woolery-Lloyd, MD, FAAD, has been appointed program development advisor for Skin of Color Update, the nation’s largest medical education event focused on dermatologic care for patients with skin of color. Dr. Woolery-Lloyd serves as director of the Skin of Color Division at the Uni
- Research Reviews Artificial Intelligence Usage in Facial Plastic Procedureshttps://modernaesthetics.com/news/research-reviews-artificial-intelligence-usage-in-facial-plastic-procedures/2483996/New research published in Clinical Otolaryngology reviews the prospects of artificial intelligence (AI) and its application in facial plastic surgery. Dr. Nuray Bayar Muluk of Kirikkale University in Turkey performed a literature search using PubMed, MEDLINE, Google, and Google Scholar s
- BTL Files Patent Infringement Lawsuit Against WonderFace Devicehttps://modernaesthetics.com/news/btl-files-patent-infringement-lawsuit-against-wonderface-device/2483957/BTL Group has filed a patent infringement claim before the Unified Patent Court against Lexter Microelectronic Engineering Systems S.L., the company behind the WonderFace device. The claim centers on BTL’s proprietary technology used in its EMFACE system, which integrates selective muscle
- Marini SkinSolutions Launches Topical Serum to Complement Neuromodulator Injectionshttps://modernaesthetics.com/news/marini-skinsolutions-launches-topical-serum-to-complement-neuromodulator-injections/2483956/Marini SkinSolutions™ has introduced NeuroSmooth™, a topical peptide-based serum formulated to support and enhance outcomes associated with neuromodulator injections. The serum contains neuromodulating peptides, collagen stimulators, and ingredients aimed at improvi
- Dr. Michelle Henry Highlights Noninvasive Periorbital Rejuvenationhttps://modernaesthetics.com/news/dr-michelle-henry-highlights-noninvasive-periorbital-rejuvenation/2483904/Understanding facial aging patterns specific to richly pigmented skin and adjusting treatment approaches accordingly, especially as patient preferences shift away from traditional lower eyelid filler, is key in managing periorbital aging in patients with skin of color, Michelle Henry, MD, FAAD, s
- Daxxify® Surpasses 1 Million Vials Distributed in US Aesthetic Markethttps://modernaesthetics.com/news/daxxify-surpasses-1-million-vials-distributed-in-us-aesthetic-market/2483419/Revance Therapeutics has announced the distribution of more than 1 million vials of daxibotulinumtoxinA-lanm (Daxxify®) for aesthetic use in the United States, marking a notable milestone 3 years after the product received US Food and Drug Administration (FDA) approval. According to a pres
- Hugel Marks 15 Years of Letybo with 2025 H.E.L.F Symposium in Seoulhttps://modernaesthetics.com/news/hugel-marks-15-years-of-letybo-with-2025-helf-symposium-in-seoul/2483385/More than 220 medical professionals from across the globe gathered in Seoul on September 14 for Hugel Inc.’s 2025 H.E.L.F. symposium, marking 15 years since the launch of its botulinum toxin, Letybo. The Hugel Expert Leader’s Forum was held at Seoul Dragon City under the theme, “K-Beau
- Study Finds Abdominoplasty Can Help Improve Urinary Incontinence Symptomshttps://modernaesthetics.com/news/study-finds-abdominoplasty-can-help-improve-urinary-incontinence-symptoms/2483374/A new study published in Aesthetic Plastic Surgery reports that abdominoplasty may contribute to improvement in urinary incontinence symptoms. The study titled “Can Abdominoplasty Relieve Symptoms of Urinary Incontinence?” systematically reviewed the existing literature to evaluate the f
- New HA Filler Obagi® saypha® MagIQ™ Approved by FDAhttps://modernaesthetics.com/news/new-ha-filler-obagi-saypha-magiq-approved-by-fda/2483329/The US Food and Drug Administration (FDA) has approved Obagi® saypha® MagIQ™, an injectable hyaluronic acid (HA) gel, marking the first product in the Obagi® saypha® collection under the Obagi Medical brand, Waldencast plc announced.